10.28.15 | Policy
The Society for Women’s Health Research strongly urges Congress to pass the Bipartisan Budget Act of 2015
The Bipartisan Budget Act of 2016 replaces sequestration equally for both defense and nondefense over the next two years. Failure to pass this critical legislation will hinder scientific discovery, compromise public health programs, and delay patients’ access to innovative medical treatments.
10.26.15 | Policy
GAO Finds NIH Has Made Progress Including Women in Research, But Improved Reporting And Analysis Needed
The Government Accountability Office (GAO) released a report, showing that more work needs to be done in reporting and analysis policies to further ensure women and minorities are being accurately represented in clinical trials.
9.17.15 | Policy
SWHR Supports Dr. Robert Califf’s Nomination to Lead FDA
President Barack Obama has nominated distinguished cardiologist and medical researcher Dr. Robert Califf to be the next U.S. Food and Drug Administration (FDA) Commissioner.
2.14.15 | Policy
Congressional Briefing Explores Biological Sex Differences in Medical Research
Women’s health leaders press for female subjects to be included in basic research
2.5.15 | Policy
SWHR Statement in Appreciation for Commissioner Hamburg’s Service
SWHR commends the outgoing Food and Drug Administration (FDA) Commissioner, Dr. Margaret Hamburg, for her profound service to improve American public health at the Agency.
1.27.15 | Policy
DeLauro NIH Funding Bill Will Provide Critically Needed Investments in Medical Research
Statement from Phyllis Greenberger, President and CEO of the Society for Women’s Health Research
1.27.15 | Policy
SWHR Submits comments to FDA Regarding Drug Trials Snapshots
The U.S. Food and Drug Administration (FDA) recently created Drug Trials Snapshots, a new website to give patients, providers, and caregivers information on the participation of people in clinical trials by sex, age, race, and ethnicity.
12.4.14 | Policy
FDA Issues Final Rule on Pregnancy and Lactation Labeling
The Food and Drug Administration announced a final rule today that sets new standards for labeling information for prescription drugs and biological products.
10.17.14 | Policy
SWHR Salutes the FDA Office of Women’s Health on 20 Years of Advancing Women’s Health
SWHR congratulates the Food and Drug Administration’s (FDA) Office of Women’s Health for 20 years of working to improve the health of women.
10.17.14 | Policy
SWHR Applauds NIH-funded Research on Gender Bias in Pre-clinical and Clinical Studies
The National Institutes of Health (NIH) announced that it will invest $10.1 million in supplemental funding to support the research of more than 80 grantees to investigate the effects of sex in pre-clinical and clinical studies.
